Cubist Systematic Strategies, LLC Akebia Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.27 - $2.24 $419,887 - $740,588	330,620 Added 488.89%	398,247 $728,000
Q4 2023 Feb 14, 2024	BUY	$0.8 - $1.28 $54,101 - $86,562	67,627 New	67,627 $83,000
Q4 2022 Feb 14, 2023	BUY	$0.25 - $0.58 $2,808 - $6,514	11,232 New	11,232 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.32 - $0.67 $5,854 - $12,257	18,295 New	18,295 $6,000
Q1 2022 May 16, 2022	SELL	$0.72 - $2.93 $114,125 - $464,425	-158,507 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.26 - $3.34 $224,253 - $331,418	99,227 Added 167.39%	158,507 $358,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.88 $153,208 - $252,956	-65,195 Reduced 52.38%	59,280 $171,000
Q2 2021 Aug 16, 2021	BUY	$2.83 - $4.2 $185,124 - $274,743	65,415 Added 110.76%	124,475 $472,000
Q1 2021 May 17, 2021	BUY	$2.92 - $5.06 $99,697 - $172,763	34,143 Added 137.03%	59,060 $200,000
Q4 2020 Feb 16, 2021	SELL	$2.22 - $3.78 $18,519 - $31,532	-8,342 Reduced 25.08%	24,917 $70,000
Q3 2020 Nov 16, 2020	SELL	$2.39 - $13.08 $142,063 - $777,488	-59,441 Reduced 64.12%	33,259 $83,000
Q2 2020 Aug 14, 2020	BUY	$6.67 - $13.58 $147,366 - $300,036	22,094 Added 31.29%	92,700 $1.26 Million
Q1 2020 May 15, 2020	BUY	$4.1 - $10.24 $76,961 - $192,215	18,771 Added 36.21%	70,606 $535,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $163,798 - $348,849	51,835 New	51,835 $328,000
Q3 2019 Nov 14, 2019	SELL	$3.55 - $5.4 $216,550 - $329,400	-61,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$4.1 - $8.05 $32,841 - $64,480	-8,010 Reduced 11.61%	61,000 $295,000
Q1 2019 May 15, 2019	BUY	$5.41 - $8.73 $84,536 - $136,414	15,626 Added 29.27%	69,010 $565,000
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $279,498 - $474,473	51,855 Added 3391.43%	53,384 $295,000
Q3 2018 Nov 14, 2018	SELL	$7.44 - $10.65 $90,797 - $129,972	-12,204 Reduced 88.87%	1,529 $14,000
Q2 2018 Aug 14, 2018	SELL	$9.15 - $11.34 $26,104 - $32,353	-2,853 Reduced 17.2%	13,733 $137,000
Q1 2018 May 15, 2018	BUY	$9.53 - $15.68 $158,064 - $260,068	16,586 New	16,586 $158,000

Others Institutions Holding AKBA

# of Institutions

120

Shares Held

54.8M

Call Options Held

291K

Put Options Held

179K

Black Rock Inc. New York, NY

11.6M
Shares

$24.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$20.8 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$11.9 Million
13.23% of portfolio
Geode Capital Management, LLC Boston, MA

4.75M
Shares

$9.84 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.72M
Shares

$7.7 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $381M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account